ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 671,34
1,34%
Dow Jones
39 134,76
0,77%
DAX
18 254,18
1,03%
Brent Oil
84,94
-0,08%
Bitcoin
64 546,36
-0,42%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. USOTC
  6. Daiichi Sankyo Company Ltd (PK) (DSNKY)

  7. Daiichi Sankyo Company Ltd (PK) (DSNKY) Actualités

DSNKY

Daiichi Sankyo (PK) (DSNKY)

Daiichi Sankyo Company Ltd (PK)
De:
Trier par:
 Showing the most relevant articles for your search:USOTC:DSNKY
DateHeureSourceTitreSymboleSociété
23/10/202308h49Dow Jones NewsAstraZeneca, Daiichi Sankyo's Enhertu Gets Approval in EU For Lung Cancer TreatmentUSOTC:DSNKYDaiichi Sankyo Company Ltd (PK)
20/10/202302h30Dow Jones NewsMerck, Daiichi Sankyo Ink Commercialization Deal for Up to $22 BillionUSOTC:DSNKYDaiichi Sankyo Company Ltd (PK)
22/09/202308h53Dow Jones NewsAstraZeneca Says Trial Results For Breast Cancer Drug Were Highly PositiveUSOTC:DSNKYDaiichi Sankyo Company Ltd (PK)
15/09/202316h51Dow Jones NewsAstraZeneca's Lung-Cancer Treatment Gets Recommended for Approval in the EUUSOTC:DSNKYDaiichi Sankyo Company Ltd (PK)
11/09/202308h55Dow Jones NewsAstraZeneca Says Datopotamab Deruxtecan Combined With Imfinzi Shows High Disease Control RatesUSOTC:DSNKYDaiichi Sankyo Company Ltd (PK)
03/07/202308h50Dow Jones NewsAstraZeneca Says Datopotamab Deruxtecan Phase 3 Trial Shows Positive Results in Lung Cancer PatientsUSOTC:DSNKYDaiichi Sankyo Company Ltd (PK)
05/06/202314h53Dow Jones NewsAstraZeneca Cancer Drug Enhertu Shows Clinically Meaningful, Durable Response in TrialUSOTC:DSNKYDaiichi Sankyo Company Ltd (PK)
14/11/202208h52Dow Jones NewsAstraZeneca Says Enhertu Recommended for EU Approval for Gastric CancerUSOTC:DSNKYDaiichi Sankyo Company Ltd (PK)
12/08/202208h53Dow Jones NewsAstraZeneca, Daiichi's Enhertu Approved by the FDA for Lung Cancer TreatmentUSOTC:DSNKYDaiichi Sankyo Company Ltd (PK)
09/08/202212h49Dow Jones NewsAstraZeneca Reports Promising Data From Lung Cancer TrialUSOTC:DSNKYDaiichi Sankyo Company Ltd (PK)
27/06/202208h55Dow Jones NewsAstraZeneca Enhertu Breast Cancer Drug Is Recommended for EU ApprovalUSOTC:DSNKYDaiichi Sankyo Company Ltd (PK)
05/05/202209h03Dow Jones NewsAstraZeneca's Enhertu Approved in US for Metastatic Breast Cancer TreatmentUSOTC:DSNKYDaiichi Sankyo Company Ltd (PK)
19/04/202208h55Dow Jones NewsAstraZeneca, Daiichi Sankyo Say FDA Has Accepted Enhertu for Priority ReviewUSOTC:DSNKYDaiichi Sankyo Company Ltd (PK)
21/02/202210h38Dow Jones NewsAstraZeneca, Daiichi Sankyo Report Positive Trial Results for Enhertu Breast-Cancer Treatment -- UpdateUSOTC:DSNKYDaiichi Sankyo Company Ltd (PK)
17/01/202208h54Dow Jones NewsAstraZeneca's Enhertu Granted Priority Review by US RegulatorUSOTC:DSNKYDaiichi Sankyo Company Ltd (PK)
17/09/202119h05Dow Jones NewsAstraZeneca Sees Positive Results for Enhertu TrialUSOTC:DSNKYDaiichi Sankyo Company Ltd (PK)
30/03/201908h02Dow Jones NewsCancer Drug Deal Carries High Price -- WSJUSOTC:DSNKYDaiichi Sankyo Company Ltd (PK)
28/07/201614h10Dow Jones NewsChina's Fosun Close to Deal for India's Gland PharmaUSOTC:DSNKYDaiichi Sankyo Company Ltd (PK)
21/04/201500h00Dow Jones NewsDaiichi Sankyo to Sell Sun Pharma StakeUSOTC:DSNKYDaiichi Sankyo Company Ltd (PK)
23/03/201522h44The Motley FoolThis Market Could Grow 6250% in 10 YearsUSOTC:DSNKYDaiichi Sankyo Company Ltd (PK)
02/12/201421h38Dow Jones NewsAbilify Maker Otsuka to Buy Avanir for $3.5 BillionUSOTC:DSNKYDaiichi Sankyo Company Ltd (PK)
24/01/201402h12Dow Jones NewsFDA Bars Ingredients From Ranbaxy's India PlantUSOTC:DSNKYDaiichi Sankyo Company Ltd (PK)
17/09/201312h43Dow Jones NewsASIA MARKETS: China Leads Asia Stocks LowerUSOTC:DSNKYDaiichi Sankyo Company Ltd (PK)
17/09/201308h03Dow Jones NewsASIA MARKETS: Asia Stocks Mostly Lower Ahead Of Fed MeetingUSOTC:DSNKYDaiichi Sankyo Company Ltd (PK)
02/09/201310h35Dow Jones NewsASIA MARKETS: Hong Kong Stocks Jump To Lead Broad Asia GainsUSOTC:DSNKYDaiichi Sankyo Company Ltd (PK)
02/09/201303h28Dow Jones NewsASIA MARKETS: Asia Stocks Rise After Official China Factory DataUSOTC:DSNKYDaiichi Sankyo Company Ltd (PK)
24/04/201312h50Dow Jones NewsNovartis Boosted by Drug LaunchesUSOTC:DSNKYDaiichi Sankyo Company Ltd (PK)
22/02/201318h20Dow Jones NewsRanbaxy Resumes Generic Lipitor Production for U.S.USOTC:DSNKYDaiichi Sankyo Company Ltd (PK)
02/10/201219h01Dow Jones NewsArQule, Daiichi Sankyo End Lung-Cancer TrialUSOTC:DSNKYDaiichi Sankyo Company Ltd (PK)
27/08/201214h04Dow Jones NewsLilly/Daiichi Blood Thinner Misses Mark in Head-to-Head Study Vs PlavixUSOTC:DSNKYDaiichi Sankyo Company Ltd (PK)
 Showing the most relevant articles for your search:USOTC:DSNKY

Dernières Valeurs Consultées

BIT
P1YL58
NLBNPIT1YL58 20991231 70...
BOV
RAIL3R
RUMO S.A ON
LSE
98OA
Perm.cust.a1br
ASX
WGL
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés